April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Rate of Recurrent Vitreous Hemorrhage after 23-Gauge Vitrectomy for Non-Clearing Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy
Author Affiliations & Notes
  • M. S. Pezda
    Ophthalmology, Kresge Eye Inst / Wayne State University, Detroit, Michigan
  • J. Apple
    Ophthalmology, Kresge Eye Inst / Wayne State University, Detroit, Michigan
  • A. Tewari
    Ophthalmology, Kresge Eye Inst / Wayne State University, Detroit, Michigan
  • Footnotes
    Commercial Relationships  M.S. Pezda, None; J. Apple, None; A. Tewari, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4212. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. S. Pezda, J. Apple, A. Tewari; Rate of Recurrent Vitreous Hemorrhage after 23-Gauge Vitrectomy for Non-Clearing Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4212.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the visual outcomes and determine the rate of recurrence of vitreous hemorrhage in patients that have undergone primary 23-gauge pars plana vitrectomy for non-clearing vitreous hemorrhage due to proliferative diabetic retinopathy.

Methods: : A retrospective review was conducted of 27 consecutive 23-gauge vitrectomy cases that were done for non-clearing vitreous hemorrhage in patients with proliferative diabetic retinopathy. All surgeries involved triamcinolone-assisted peeling of the internal limiting membrane and panretinal photocoagulation with an endolaser probe. Patients with less than one month follow-up were excluded. Data that was reviewed included pre-operative visual acuity and best corrected visual acuity at most recent follow-up. In addition, recurrent vitreous hemorrhage that occurred in the post-operative period was noted, as well as any interventions, including repeat vitrectomy. Status of the intraocular lens was also recorded. Comparison between pre-operative and final visual acuity was performed using the Wilcoxon signed rank test.

Results: : Of the 27 vitrectomies performed, there were 22 males and 5 females and the mean age was 57 years. Mean follow-up was 6.5 months. There were 22 phakic patients and 5 pseudophakic patients. Mean pre-operative visual acuity was 20/800 (20/50 to LP) and mean final visual acuity was 20/250 (20/25 to HM) (p=0.044). Twenty one patients (78%) remained clear of vitreous hemorrhage in the postoperative period. Six patients (22%) had a recurrence of vitreous hemorrhage, with 4 patients (15%) requiring repeat vitrectomy. Mean interval between surgeries was 3 months (range 2 to 5 months). All 4 patients remained clear of hemorrhage after repeat vitrectomy.

Conclusions: : Twenty-three gauge pars plana vitrectomy is an effective surgical technique for diabetic non-clearing vitreous hemorrhage. Although there have been concerns with small gauge vitrectomy and the ability to place adequate peripheral laser treatment, our results compared favorably with published literature on 20-gauge surgery.

Keywords: diabetic retinopathy • vitreoretinal surgery • proliferative vitreoretinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×